| Pathogens | All VAT patients (N = 34) | VAT did not progressed to VAP (N = 27) | VAT progressed to VAP (N = 7) |
| Gram-Positive Cocci Methicillin-resistant Staphylococcus aureus | 13 (38%) | 12 (44%) | 1 (14%) |
| Methicillin-sensitive Staphylococcus aureus | 6 (18%) | 2 (7%) | 4 (57%) |
| Enterococcus species | 2 (6%) | 2 (7%) | 0 |
| Gram-Negative Pathogens Psudomonas aeruginosa | 3 (9%) | 2 (7%) | 1 (14%) |
| Escherichia coli | 2 (6%) | 1 (4%) | 1 (14%) |
| Klebsiella pneumoniae | 5 (15%) | 4 (15%) | 1 (14%) |
| Klebsiella oxytoca | 1 (3%) | 0 | 1 (14%) |
| Enterobacter species | 1(3%) | 1 (4%) | 0 |
| Serratia marcescens | 2 (6%) | 2 (7%) | 0 |
| Proteus mirabilis | 1 (3%) | 1 (4%) | 0 |
| Stenotrophomonas maltophilia | 2 (6%) | 1 (4%) | 1 (14%) |
| Acinectobacter baumannii | 1 (3%) | 1 (4%) | 0 |
| Chryseobacterium species | 1 (3%) | 1 (4%) | 0 |
| Haemophilus influenza | 2 (6%) | 1 (4%) | 1 (14%) |
| One Pathogen | 27 (79%) | 23 (86%) | 4 (57%) |
| Two Pathogens | 4 (12%) | 2 (7%) | 2 (29%) |
| Three Pathogens | 3 (9%) | 2 (7%) | 1 (14%) |